These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 314300)

  • 1. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
    Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
    Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
    Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
    Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopathology of non-Hodgkin lymphomas.
    Huber H; Gattringer C; Knapp W; Stein H
    Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of surface receptors with histological appearance in 29 cases of non-Hodgkin lymphoma.
    Habeshaw JA; Macaulay RA; Stuart AE
    Br J Cancer; 1977 Jun; 35(6):858-67. PubMed ID: 301396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification.
    Stein H; Papadimitriou CS; Bouman H; Lennert K; Fuchs J
    Recent Results Cancer Res; 1978; 64():158-75. PubMed ID: 366694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of peanut lectin to germinal-centre cells: a marker for B-cell subsets of follicular lymphoma?
    Rose ML; Habeshaw JA; Kennedy R; Sloane J; Wiltshaw E; Davies AJ
    Br J Cancer; 1981 Jul; 44(1):68-74. PubMed ID: 6789856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
    Stein H
    Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinico-pathological and immunological study of unfavourable non-Hodgkin lymphomas. Comparison of the Rappaport and Kiel classifications.
    Lindemalm C; Christensson B; Johansson B; Mellstedt H; Ost A; Biberfeld P
    Acta Pathol Microbiol Immunol Scand A; 1983 Nov; 91(6):435-43. PubMed ID: 6364692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
    Pinkus GS; Said JW
    Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Ia-like antigen in lymphatic leukaemias and non-hodgkin lymphomas in correlation with other surface markers.
    Bergmann L; Mitrou PS; Cherdron T; Holloway K; Jost J; Timm V; Zerth G
    Scand J Haematol; 1982 Sep; 29(3):224-34. PubMed ID: 6983113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological classification of lymphoma and lymphocytic leukemias (author's transl)].
    Derre M; Tubiana N; Carcassonne Y
    Sem Hop; 1980 Dec 18-25; 56(47-68):1999-2003. PubMed ID: 6256913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune marker expression in 53 lymphomas of high-grade malignancy.
    Pallesen G; Madsen M; Schifter S
    Histopathology; 1983 Nov; 7(6):841-57. PubMed ID: 6689315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-surface-marker phenotyping in patients with leukemic non-Hodgkin lymphomas (NHL) of low and intermediate malignancy.
    Herrmann F; Wirthmüller R
    Immunobiology; 1982 Oct; 163(1):77-94. PubMed ID: 7173978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant lymphoma of the testis.
    Baldetorp LA; Brunkvall J; Cavallin-Ståhl E; Henrikson H; Holm E; Olsson AM; Akerman M
    Br J Urol; 1984 Oct; 56(5):525-30. PubMed ID: 6398719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-associated immunoglobulin in human non-Hodgkin lymphomas. A comparative study of surface immunoglobulin on cells in suspension and cytoplasmic immunoglobulin by immunohistochemistry.
    Landaas TO; Godal T; Marton PF; Kvaløy S; Langholm R; Lindmo T; Jørgensen OG; Høst H
    Acta Pathol Microbiol Scand A; 1981 Mar; 89(2):91-101. PubMed ID: 7023187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retrospective analysis of the clinical relevance of the Kiel classification of malignant non-Hodgkin's lymphomas (author's transl)].
    Brittinger G; Bartels H; Bremer K; Burger A; Dühmke E; Gunzer U; König E; Stacher A; Stein H; Theml H; Waldner R
    Strahlentherapie; 1977 Apr; 153(4):222-8. PubMed ID: 324031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group.
    Brittinger G; Bartels H; Common H; Dühmke E; Fülle HH; Gunzer U; Gyenes T; Heinz R; König E; Meusers P
    Hematol Oncol; 1984; 2(3):269-306. PubMed ID: 6384008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of two major B cell forms of nodular mixed lymphoma.
    Grogan TM; Hicks MJ; Jolley CS; Rangel CS; Jones SE
    Lab Invest; 1984 Nov; 51(5):504-14. PubMed ID: 6387274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictability of immunologic phenotype of malignant lymphomas by conventional morphology: a study of 60 cases.
    Frizzera G; Gajl-Peczalska KJ; Bloomfield CD; Kersey JH
    Cancer; 1979 Apr; 43(4):1216-24. PubMed ID: 376087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.